QUANTA THERAPEUTICS
Summary
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 41 M
Avg. Deal Size£ 41 M
Senior Management
Perry Nisen
CEO
Heather Meeks
Executive Administrative Assistant
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite